Press "Enter" to skip to content

Seattle Genetics Dives Despite Positive Bladder Cancer Treatment Test – Investor’s Business Daily

admin 0

Seattle Genetics Dives Despite Positive Bladder Cancer Treatment Test  Investor’s Business Daily

Seattle Genetics stock initially neared a breakout Thursday before closing down after its bladder cancer treatment topped expectations in a midstage test.

“bladder cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *